A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

NCT05200286 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

F2G Biotech GmbH